Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5646 record(s)

Req # A-2023-001618

Adverse Drug Reactions (ADRs). Report numbers: 001072019.

Organization: Health Canada

2 page(s)
April 2024

Req # A-2024-000007

Adverse Drug Reactions (ADRs) for Heparin. Report numbers: 001072985.

Organization: Health Canada

8 page(s)
April 2024

Req # A-2024-000012

Adverse Drug Reactions (ADRs). Report numbers: 001067949, 001069982.

Organization: Health Canada

17 page(s)
April 2024

Req # A-2024-000017

Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number: 1026516, 1043922. ADRs for HYDROXYCHLOROQUINE. Report numbers: 1024918, 1026702, 1037377.

Organization: Health Canada

70 page(s)
April 2024

Req # A-2024-000028

Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.

Organization: Health Canada

29 page(s)
April 2024

Req # A-2024-000032

Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.

Organization: Health Canada

76 page(s)
April 2024

Req # A-2024-000068

Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.

Organization: Health Canada

3 page(s)
April 2024

Nothing to report this month

Organization: Canadian Museum of Nature

April 2024

Req # A-2019-0013

All data and emails received and/or prepared from March 1, 2019 until December 2, 2019 regarding vaping related illnesses.

Organization: Canadian Institutes of Health Research

431 page(s)
March 2024

Req # A-2021-0021

All reports, briefing notes, budgets, and emails/correspondence pertaining to the New Brunswick Cluster of Neurological Syndrome of Unknown Cause, produced between January 1, 2020, and Nov 18, 2021.

Organization: Canadian Institutes of Health Research

1112 page(s)
March 2024
Date modified: